Larry W. Moreland
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies 168
- Systemic Lupus Erythematosus Research 80
- Hematology top 0.1%
- Autoimmune and Inflammatory Disorders Research 51
- Immunology top 0.2%
- T-cell and B-cell Immunology 12
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 36
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 24
-
- Monoclonal and Polyclonal Antibodies Research 60
-
- Vasculitis and related conditions 23
- Co-authors
- Michael SchiffEdward KeystoneRoy FleischmannMark C. GenoveseArthur L. WeaverMichael E. WeinblattStanley CohenJoan M. Bathon
- Cited by
- RheumatologyHematologyImmunology
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Larry W. Moreland
279 papers receiving 18.0k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Rheumatology 12.2k
- Hematology 5.0k
- Immunology 4.7k
- Genetics 2.4k
- Pathology and Forensic Medicine 2.3k
Countries citing papers authored by Larry W. Moreland
This map shows the geographic impact of Larry W. Moreland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry W. Moreland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry W. Moreland more than expected).
Fields of papers citing papers by Larry W. Moreland
This network shows the impact of papers produced by Larry W. Moreland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry W. Moreland. The network helps show where Larry W. Moreland may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Larry W. Moreland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 13 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 2 | |
| 8 | 2019 | 21 | |
| 9 | 2018 | 3 | |
| 10 | 2017 | 22 | |
| 11 | 2013 | 26 | |
| 12 | 2009 | 1 | |
| 13 | Rheumatology and immunology therapy : A to Z essentials | 2004 | 2 |
| 14 | TNF[alpha]-inhibition in the treatment of rheumatoid arthritis | 2003 | 2 |
| 15 | 2003 | 3 | |
| 16 | Rheumatoid arthritis : epidemiology, pathogenesis and treatment | 2001 | 3 |
| 17 | Safety Of Combination Therapy With Anakinra And Etanercept In Patients With Rheumatoid Arthritis. | 2001 | 23 |
| 18 | Recombinant Human Relaxin in the Treatment of Scleroderma | 2000 | 44 |
| 19 | Comparison of aminobenzoate potassium and placebo in the treatment of scleroderma. | 1994 | 13 |
| 20 | Rheumatoid vasculitis with intrarenal aneurysm formation. | 1988 | 3 |
About Larry W. Moreland
Larry W. Moreland is a scholar working on Rheumatology, Hematology and Genetics, having authored 291 papers that have together received 18.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (168 papers), Systemic Lupus Erythematosus Research (80 papers), Monoclonal and Polyclonal Antibodies Research (60 papers), Autoimmune and Inflammatory Disorders Research (51 papers), Chronic Lymphocytic Leukemia Research (36 papers), Lymphoma Diagnosis and Treatment (24 papers), Vasculitis and related conditions (23 papers) and T-cell and B-cell Immunology (12 papers). The work is most often cited by research in Rheumatology (12.2k citations), Hematology (5.0k citations) and Immunology (4.7k citations). Larry W. Moreland has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Michael Schiff, Edward Keystone, Roy Fleischmann, Mark C. Genovese, Arthur L. Weaver, Michael E. Weinblatt, Stanley Cohen, Joan M. Bathon, Joel M. Kremer and Michael H. Weisman. Their work appears in journals such as New England Journal of Medicine, Circulation and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.